Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection

Journal of Chromatography B: Biomedical Sciences and Applications

Volumn 734, Issue 2, 1999, Pages 229-246

  Kristoffersen, L ^a   Bugge, A ^a   Lundanes, E ^b   Slordal L ^a,c  

^a Natl Inst of Forensic Toxicology   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Citalopram; Fluoxetine; Paroxetine

Indexed keywords

4 (4 FLUOROPHENYL) 3 (3 HYDROXY 4 METHOXYPHENOXYMETHYL)PIPERIDINE; 4 (4 FLUOROPHENYL) 3 (4 HYDROXY 3 METHOXYPHENOXYMETHYL)PIPERIDINE; BRL 36583A; BRL 36610A; CITALOPRAM; DRUG METABOLITE; FLUOXETINE; NORCITALOPRAM; NORFLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ISOLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PLASMA; PRIORITY JOURNAL;

ACETONITRILES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITALOPRAM; FLUOXETINE; HUMANS; HYDROGEN-ION CONCENTRATION; PAROXETINE; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SEROTONIN UPTAKE INHIBITORS; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0032702157     PISSN: 13872273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(99)00352-7     Document Type: Article

References (28)

1. Mourilhe P., Stokes P.E. Drug Safety. 18:1998;57.
2. Lane R., Baldwin D., Preskorn S. J. Psychopharmacol. 9:1995;163.
3. Gunasekara N.S., Noble S., Benfield P. Drugs. 55:1998;85.
4. Isacsson G., Holmgren P., Druid H., Bergman U. Acta Psychiatr. Scand. 96:1997;94.
5. Worm K., Dragsholt C., Simonsen K., Kringsholm B. Int. J. Legal Med. 111:1998;188.
6. Öström M., Eriksson A., Thorson J., Spigset O. Lancet. 348:1996;339.
7. Druid H., Holmgren P. Läkartidningen. 93:1996;4149.
8. Kincaid R.L., McMullin M.M., Crookham S.B., Rieders F. J. Anal. Toxicol. 14:1990;327.
9. Singer P.S., Jones G.R. J. Anal. Toxicol. 21:1997;518.
10. Neuvonen P.J., Pohjola-Sintonen S., Tacke U., Vuori E. Lancet. 342:1993;1419.
11. Rohrig T.P., Prouty R.W. J. Anal. Toxicol. 13:1989;305.
12. Sternbach H. Am. J. Psychiatry. 148:1991;705.
13. Ferslew K.E., Hagardorn A.N., Harlan G.C., McCormick W.F. J. Forensic Sci. 43:1998;1082.
14. Kratz A., Lewandrowski K.B. New Engl. J. Med. 339:1998;1063.
15. Milne R.J., Goa K.L. Drugs. 41:1991;450.
16. Haddock R.E., Johnson A.M., Langley P.F., Nelson D.R., Pope J.A., Thomas D.R., Woods F.R. Acta Psychiatr. Scand. 80:1989;24.
17. Crewe H.K., Lennard M.S., Tucker G.T., Woods F.R., Haddock R.E. Br. J. Clin. Pharmacol. 34:1992;262.
18. Altamura A.C., Moro A.R., Percudani M. Clin. Pharmacokinet. 26:1994;201.
19. Eap C.B., Baumann P. J. Chromatogr. B. 686:1996;51.
20. Åkerman K.K., Jolkkonen J., Huttunen H., Penttilä I. Ther. Drug Monit. 20:1998;25.
21. Aymard G., Livi P., Pham Y.T., Diquet B. J. Chromatogr. B. 700:1997;183.
22. Alvarez J.-C., Bothau D., Collignon I., Advenier C., Spreux-Varoquaux O. J. Chromatogr. B. 707:1998;175.
23. Carlsson B., Norlander B. J. Chromatogr. B. 702:1997;234.
24. Crifasi J.A., Le N.X., Long C. J. Anal. Toxicol. 21:1997;415.
25. Eap C.B., Gaillard N., Powell K., Baumann P. J. Chromatogr. B. 682:1996;265.
26. Eap C.B., Bouchoux G., Amey M., Cochard N., Savary L., Baumann P. J. Chromatogr. Sci. 36:1998;365.
27. Box G.E.P., Hunter W.G. Statistics For Experimenters - An Introduction to Design, Data Analysis and Model Building. 1978;Wiley, New York.
28. Horwitz W. Parkany M. The Use of Recovery Factors in Trace Analysis. 1996;1 Royal Society of Chemistry, Cambridge.